Charles Anthony Graham Baker-Glenn

Title: Charles Anthony Graham Baker-Glenn: Innovator in Pharmaceutical Chemistry

Introduction

Charles Anthony Graham Baker-Glenn is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating various medical conditions. His work is characterized by a focus on innovative solutions for women's health issues.

Latest Patents

Baker-Glenn holds a patent for N-piperidin-4-yl derivatives. This invention relates to a N-piperidin-4-yl derivative having the general Formula I or a pharmaceutically acceptable salt thereof. The patent encompasses pharmaceutical compositions that include these derivatives and their use for the treatment and prevention of endometriosis, pre-menopausal and peri-menopausal hormone-dependent breast cancer, contraception, and the treatment of uterine fibroids or other menstrual-related disorders. He has 1 patent to his name.

Career Highlights

Baker-Glenn is currently employed at Merck Sharp & Dohme B.V., a leading global healthcare company. His role involves research and development in the pharmaceutical sector, where he applies his expertise to create innovative solutions for pressing health issues.

Collaborations

Throughout his career, Baker-Glenn has collaborated with talented professionals in the field, including Ines Huisman and Marcelis Van Der Stelt. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Charles Anthony Graham Baker-Glenn is a distinguished inventor whose work in pharmaceutical chemistry has the potential to significantly impact women's health. His innovative approach and dedication to research continue to drive advancements in the field.